Scopus
Permanent URI for this collectionhttps://premium.gcris.co/handle/123456789/32
Browse
Browsing Scopus by Scopus Q "Q2"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Journal Article Citation - WoS: 4Citation - Scopus: 4Convergence analysis and numerical solution of the benjamin-bona-mahony equation by lie-trotter splitting(Tubitak Scientific & Technological Research Council Turkey, 2018) Zurnaci, Fatma; Gucuyenen Kaymak, Nurcan; Seydaoglu, Muaz; Tanoglu, GamzeIn this paper, an operator splitting method is used to analyze nonlinear Benjamin-Bona-Mahony-type equations. We split the equation into an unbounded linear part and a bounded nonlinear part and then Lie-Trotter splitting is applied to the equation. The local error bounds are obtained by using the approach based on the differential theory of operators in a Banach space and the quadrature error estimates via Lie commutator bounds. The global error estimate is obtained via Lady Windermere's fan argument. Finally, to confirm the expected convergence order, numerical examples are studied.Peer Review Citation - WoS: 10Citation - Scopus: 11An update on molecular biology and drug resistance mechanisms of multiple myeloma(Elsevier Science inc, 2015) Mutlu, Pelin; Kiraz, Yagmur; Gunduz, Ufuk; Baran, Yusuf; Baran, YusufMultiple myeloma (MM), a neoplasm of plasma cells, is the second most common hematological malignancy. Incidance rates increase after age 40. MM is most commonly seen in men and African-American population. There are several factors to this, such as obesity, environmental factors, family history, genetic factors and monoclonal gammopathies of undetermined significance (MGUS) that have been implicated as potentially etiologic. Development of MM involves a series of complex molecular events, including chromosomal abnormalities, oncogene activation and growth factor dysregulation. Chemotherapy is the most commonly used treatment strategy in MM. However, MM is a difficult disease to treat because of its marked resistance to chemotherapy. MM has been shown to be commonly multidrug resistance (MDR)-negative at diagnosis and associated with a high incidence of MDR expression at relapse. This review deals with the molecular aspects of MM, drug resistance mechanisms during treatment and also possible new applications for overcoming drug resistance. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
